Profil
Edward W.
Bernton worked as a Medical Director at CytImmune Sciences, Inc., Chief Science Officer & Medical Director at Analytica Therapeutics, Inc., and Chief Scientific Officer at Protalex, Inc. He earned a doctorate degree from Georgetown University in 1978.
Anciens postes connus de Edward W. Bernton
| Sociétés | Poste | Fin |
|---|---|---|
CytImmune Sciences, Inc.
 CytImmune Sciences, Inc. BiotechnologyHealth Technology CytImmune Sciences, Inc. operates as a clinical stage oncology company. It develops and manufactures cytokine immunoassay kits. The company was founded by Lawrence Tamarkin and Giulio F. Paciotti in 1998 and is headquartered in Rockville, MD. | Directeur Technique/Scientifique/R&D | - |
| PROTALEX, INC. | Directeur Technique/Scientifique/R&D | - |
| Analytica Therapeutics, Inc. | Directeur Technique/Scientifique/R&D | - |
Formation de Edward W. Bernton
| Georgetown University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Protalex, Inc.
 Protalex, Inc. Pharmaceuticals: MajorHealth Technology Protalex, Inc. engages in the development of a class of biopharmaceutical drugs for treating autoimmune and inflammatory diseases including rheumatoid arthritis and Immune Thrombocytopenia. Its lead product is PRTX-100 which is a bacterial protein known to modify aspects of the human immune system. The company was founded by John E. Doherty on September 17, 1999 and is headquartered in Florham Park, NJ. | Health Technology |
CytImmune Sciences, Inc.
CytImmune Sciences, Inc. BiotechnologyHealth Technology CytImmune Sciences, Inc. operates as a clinical stage oncology company. It develops and manufactures cytokine immunoassay kits. The company was founded by Lawrence Tamarkin and Giulio F. Paciotti in 1998 and is headquartered in Rockville, MD. | Health Technology |
| Analytica Therapeutics, Inc. |
